Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That is Recurrent, Metastatic, or Cannot Be Removed by Surgery
National Cancer Institute (NCI)
National Cancer Institute (NCI)
NRG Oncology
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Seagen Inc.
Genmab
Seagen Inc.
Fulgent Pharma LLC.
University of Chicago
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
Medical College of Wisconsin
M.D. Anderson Cancer Center
Hoffmann-La Roche
Gustave Roussy, Cancer Campus, Grand Paris
West China Hospital
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
Cedars-Sinai Medical Center
Northwell Health
National Cancer Institute (NCI)
University of Michigan Rogel Cancer Center
Gilead Sciences
Massachusetts Eye and Ear Infirmary
Arcus Biosciences, Inc.
Erasca, Inc.
R-Pharm
China Medical University Hospital
Assistance Publique - Hôpitaux de Paris
M.D. Anderson Cancer Center
PT. Prodia Stem Cell Indonesia
South Egypt Cancer Institute
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Rutgers, The State University of New Jersey
Bayer
Royal College of Surgeons, Ireland
Abramson Cancer Center at Penn Medicine
Duke University
M.D. Anderson Cancer Center
Merus B.V.
M.D. Anderson Cancer Center
Pfizer
University of California, Davis
Boehringer Ingelheim
M.D. Anderson Cancer Center